20161104 IVIg induced B cells qPCR: pre-array test

OBJECTIVES

– To test whether  stimulated B cells differentially express IL-10 and/or Fcgr2b genes upon IVIg treatment.

MATERIALS

– High Capacity RNA-to-cDNA Kit  (Ref:4387406, Applied Biosystems)

– TaqMan Universal Master Mix II with UNG (Ref:4440042, Applied Biosystems)

– Human IL-10 Assay Hs00961622-m1 (Applied Biosystems)

– Human Fcgr2b Assay Hs01634996-s1 (Applied Biosystems)

– Human GAPDH Assay Hs99999905-m1 (Applied Biosystems)

– Human 18S Assay Hs99999901-s1 (Applied Biosystems)

PROTOCOLS

A) RT (20161104)

Samples were retrotranscribed according to the following protocol. A blank sample (w/o RNA template) as a negative control was  added to the reaction.

n=1MM (n=18+2=20)
2X RT Buffer10 mcL200 mcL
20X RT Enzyme mix1 mcL20 mcL
Nuclease-free H2Oqsp. 20 mcL-
Sampleup to 9 mcL-
Total per reaction20 mcLAdd 11 mcL per microtube

200 ng of sample RNA were used in each 20 mcLreaction. The following volumes were added per microtube.

DatosTTOCuantificación RNAVolumen muestra RT
(200 ng)
Volumen H2O RT
(qsp 9 mcl)
Nº individuoNombreIVIgConcentración
(ng/mcL)
mcLmcL
1CintaNO 88,72.25479143179266.7452085682074
SI 114,31.74978127734037.2502187226597
2ElenaNO186,7
1.07123727905737.9287627209427
SI89,42.23713646532446.7628635346756
3JordiNO 223,8
0.893655049151038.106344950849
SI 198,71.00654252642177.9934574735783
4NoemiNO150,6
1.328021248347.67197875166
SI114,61.74520069808037.2547993019197
5TomasNO109,3
1.82982616651427.1701738334858
SI105,41.89753320683117.1024667931689
6RicardNO 134,8
1.48367952522267.5163204747774
SI 130,51.53256704980847.4674329501916
7XaviNO 159,9
1.25078173858667.7492182614134
SI 246,80.810372771474888.1896272285251
9CeliaNO151.41.32100396301197.6789960369881
SI176.21.13507377979577.8649262202043
10NachoNO211.20.94696969696978.0530303030303
SI164.41.21654501216557.7834549878346

The thermal cycler conditions were as follows, as indicated by Applied (total volume 20 mcL):

Step 1Step 2Step 3
Temperature (º C)37954
Time60 min5 min Infinite Hold

C)  qPCR (20161107)

Samples were analized in triplets and two blank samples were added to the reaction as  negative controls: one sample w/o cDNA template (qPCR blank) and the  RT negative control.

The following  protocol was used:

N=1MM per detector (n=54+3)
Taqman Universal Master Mix II10 mcL570 mcL
Taqman Gene Expression Assay 1 mcL57 mcL
cDNA template+ H2Oup to 9 mcL*-
Total volume20 mcLAdd 11 mcL per well

 0,6 mcL of  sample (200ng/20 mcL*0,6 mcL=6 ng) and 8,4 mcL of water  were added per well. Since 12 wells (n=12+2=14) were analized per sample, a mastermix of  8,4 mcl of sample+ 117,6 mcl of water.  

The thermal cycler conditions were as follows, as indicated by Applied (total volume 20 mcL):

UNG incubation (Hold)Polymerase activation (Hold)PCR (40 cycles)
Temperature (ºC)509595 + 60
Time (mm:ss)2:0010:0000:15 + 1:00

RESULTS

20161107

layout-1

CONCLUSIONS

Stimulated B cells do not differentially express IL-10 or Fcgr2b genes upon IVIg treatment.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.